Arrowhead Pharmaceuticals, Inc. (ARWR) stock
ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$47.78+0.63 (+1.34%)
Close on Nov 13, 2026Market cap $6.75BP/E –Yield –
Arrowhead Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Arrowhead Pharmaceuticals's enterprise value was $5.36B on Nov 11, 2026, against $6.27B a year earlier. Over the last 5 years it ranged from $1.05B to $10.10B, with a median of $3.51B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.36B | -34.0% |
| 2025 | Dec 31, 2025 | $8.13B | +388.7% |
| 2024 | Dec 31, 2024 | $1.66B | -42.6% |
| 2023 | Dec 29, 2023 | $2.90B | -31.2% |
| 2022 | Dec 30, 2022 | $4.21B | -36.3% |
| 2021 | Dec 31, 2021 | $6.61B | -13.4% |
| 2020 | Dec 31, 2020 | $7.63B | +30.7% |
| 2019 | Dec 31, 2019 | $5.84B | +445.1% |
| 2018 | Dec 31, 2018 | $1.07B | +324.6% |
| 2017 | Dec 29, 2017 | $252.14M | +920.0% |
| 2016 | Dec 30, 2016 | $24.72M | -91.3% |
| 2015 | Dec 31, 2015 | $284.43M | +14.4% |
| 2014 | Dec 31, 2014 | $248.65M | -22.9% |
| 2013 | Dec 31, 2013 | $322.65M | +1179.8% |
| 2012 | Dec 31, 2012 | $25.21M | -11.4% |
| 2011 | Dec 30, 2011 | $28.45M | -49.5% |
| 2010 | Dec 31, 2010 | $56.37M | – |
See a number that looks wrong?